New EU Approvals
Executive Summary
The Pink Sheet’s list of EU centralized approvals of new active substances now includes a new product, Alexion Pharmaceuticals' Ultomiris, for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).